I posted about ChemImage Corp. v. Johnson & Johnson earlier this year.
Over at Law360, Lisa Bernstein, Reginald R. Goeke, and Brad L. Peterson provide a more detailed evaluation of the case and the joint steering committee model for business planning that was at issue. They first note that companies are increasingly implementing growth and innovation strategies through long-term contracts and strategic alliances. In these contracts, the parties’ critical decisions are left open for joint resolution.
The joint steering committee provisions are written, the authors say, in a “business voice” and employ nebulous terms like “good faith” and “reasonable commercial efforts.” The joint steering committee provisions could thus reasonably be seen as merely helpful process guidance, rather than legally binding commitments. In ChemImage, the District Court for the Southern District of New York weighed in on how to treat such provisions.
The parties’ contract in ChemImage expressly delegated the determination of whether a development milestone was met to a joint steering committee. However, one party terminated the agreement for cause, claiming that a milestone had not been met, without submitting that issue to the joint steering committee for its determination. This was breach, said the court. In this instance, at least, the court viewed the joint steering committee provisions as giving rise to enforceable legal obligations.
The authors conclude with a short discussion of the implications of the decision for practicing attorneys.
Get the full article here.
Recent Comments